2018 Annual Sessions

SYM26 - SYMPOSIUM 26 - Can My Lung Transplant Candidate Take This Medication? What to Do with the New Drugs for Lung Failure

Apr 13, 2018 2:00pm ‐ Apr 13, 2018 3:55pm


Description

Use of Anticoagulation or Anti-Platelet Therapy While Waiting: Can It Be Done Safely?
Matthew Hartwig, MD

Is it Safe to Use mTOR Inhibition (Sirolimus or Everolimus) While Awaiting Lung Transplantation in Lymphangioleiomyomatosis (LAM)?
Daniel Dilling, MD

Planning for the Far Side: Antimicrobial Agents in Patients on the Wait List for Lung Transplantation
Orla Morrissey, MD

Are the Novel Antifibrotic Medications Safe for Use in Candidates for Lung Transplantation?
Hilary Goldberg, MD

Lumacaftor/Ivacaftor Use Before and After Transplant in Cystic Fibrosis: Is It Indicated?
Adam Cochrane, PharmD

Analgesia and Neuropharmacology: What is Acceptable in Lung Transplant Candidates
Linda Stuckey Fitzgerald, PharmD, BCPS

Speaker(s):

You must be logged in and own this session in order to post comments.